Market Research Logo

Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016

Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘Sunovion Pharmaceuticals Inc. - Product Pipeline Review - 2016’, provides an overview of the Sunovion Pharmaceuticals Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sunovion Pharmaceuticals Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sunovion Pharmaceuticals Inc.
The report provides overview of Sunovion Pharmaceuticals Inc. including its business description, key facts, and locations and subsidiaries
The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
The report assesses Sunovion Pharmaceuticals Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
The report features Sunovion Pharmaceuticals Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sunovion Pharmaceuticals Inc.’s strategic position with total access to detailed information on its product pipeline
Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of therapeutics under development for Sunovion Pharmaceuticals Inc.
Identify potential new clients or partners in the target demographic
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
Devise corrective measures for pipeline projects by understanding Sunovion Pharmaceuticals Inc.’s pipeline depth and focus of pipeline therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Table of Contents
List of Tables
List of Figures
Sunovion Pharmaceuticals Inc. Snapshot
Sunovion Pharmaceuticals Inc. Overview
Key Information
Key Facts
Sunovion Pharmaceuticals Inc. - Research and Development Overview
Key Therapeutic Areas
Sunovion Pharmaceuticals Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Sunovion Pharmaceuticals Inc. - Pipeline Products Glance
Sunovion Pharmaceuticals Inc. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Sunovion Pharmaceuticals Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Sunovion Pharmaceuticals Inc. - Early Stage Pipeline Products
IND/CTA Filed Products/Combination Treatment Modalities
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Sunovion Pharmaceuticals Inc. - Drug Profiles
eslicarbazepine acetate
Product Description
Mechanism of Action
R&D Progress
dasotraline
Product Description
Mechanism of Action
R&D Progress
glycopyrrolate
Product Description
Mechanism of Action
R&D Progress
DSP-2230
Product Description
Mechanism of Action
R&D Progress
DSP-3748
Product Description
Mechanism of Action
R&D Progress
SEP-363856
Product Description
Mechanism of Action
R&D Progress
SEP-360
Product Description
Mechanism of Action
R&D Progress
SEP-39
Product Description
Mechanism of Action
R&D Progress
Small Molecule 1 for Neuropsychiatric Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Neuropsychiatric Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit D-amino acid oxidase for Neuropathic Pain, Inflammatory Pain and Memory Impairment
Product Description
Mechanism of Action
R&D Progress
EP-103
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Central Nervous System Disorders
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Modulate GPCR and Ion Channel for Psychiatric Disorders
Product Description
Mechanism of Action
R&D Progress
Sunovion Pharmaceuticals Inc. - Pipeline Analysis
Sunovion Pharmaceuticals Inc. - Pipeline Products by Target
Sunovion Pharmaceuticals Inc. - Pipeline Products by Route of Administration
Sunovion Pharmaceuticals Inc. - Pipeline Products by Molecule Type
Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action
Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates
Sunovion Pharmaceuticals Inc. - Dormant Projects
Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
dasotraline
DSP-1053
DSP-8658
SEP-228432
tecastemizole
Sunovion Pharmaceuticals Inc. - Locations and Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Sunovion Pharmaceuticals Inc., Key Information
Sunovion Pharmaceuticals Inc., Key Facts
Sunovion Pharmaceuticals Inc. - Pipeline by Indication, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2016
Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2016
Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2016
Sunovion Pharmaceuticals Inc. - Partnered Products/ Combination Treatment Modalities, 2016
Sunovion Pharmaceuticals Inc. - Pre-Registration, 2016
Sunovion Pharmaceuticals Inc. - Phase III, 2016
Sunovion Pharmaceuticals Inc. - Phase II, 2016
Sunovion Pharmaceuticals Inc. - Phase I, 2016
Sunovion Pharmaceuticals Inc. - IND/CTA Filed, 2016
Sunovion Pharmaceuticals Inc. - Preclinical, 2016
Sunovion Pharmaceuticals Inc. - Discovery, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Target, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2016
Sunovion Pharmaceuticals Inc. - Pipeline Products by Mechanism of Action, 2016
Sunovion Pharmaceuticals Inc. - Recent Pipeline Updates, 2016
Sunovion Pharmaceuticals Inc. - Dormant Developmental Projects,2016
Sunovion Pharmaceuticals Inc. - Discontinued Pipeline Products, 2016
Sunovion Pharmaceuticals Inc., Other Locations
Sunovion Pharmaceuticals Inc., Subsidiaries
List of Figures
Sunovion Pharmaceuticals Inc. - Pipeline by Top 10 Indication, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Stage of Development, 2016
Sunovion Pharmaceuticals Inc. - Monotherapy Products in Pipeline, 2016
Sunovion Pharmaceuticals Inc. - Partnered Products in Pipeline, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Top 10 Target, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Route of Administration, 2016
Sunovion Pharmaceuticals Inc. - Pipeline by Molecule Type, 2016
Sunovion Pharmaceuticals Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report